Cegedim SA
PAR:CGM
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
11.3
19.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one CGM stock under the Base Case scenario is 33.97 EUR. Compared to the current market price of 11.3 EUR, Cegedim SA is Undervalued by 67%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Cegedim SA
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for CGM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Cegedim SA
Balance Sheet Decomposition
Cegedim SA
Current Assets | 338.3m |
Cash & Short-Term Investments | 35.4m |
Receivables | 269.2m |
Other Current Assets | 33.6m |
Non-Current Assets | 645.4m |
Long-Term Investments | 26.2m |
PP&E | 142.1m |
Intangibles | 442.5m |
Other Non-Current Assets | 34.5m |
Current Liabilities | 384.7m |
Accounts Payable | 57.2m |
Other Current Liabilities | 327.5m |
Non-Current Liabilities | 320.3m |
Long-Term Debt | 264m |
Other Non-Current Liabilities | 56.3m |
Earnings Waterfall
Cegedim SA
Revenue
|
634m
EUR
|
Cost of Revenue
|
-514.1m
EUR
|
Gross Profit
|
119.9m
EUR
|
Operating Expenses
|
-99.9m
EUR
|
Operating Income
|
20m
EUR
|
Other Expenses
|
-18m
EUR
|
Net Income
|
2m
EUR
|
Free Cash Flow Analysis
Cegedim SA
EUR | |
Free Cash Flow | EUR |
CGM Profitability Score
Profitability Due Diligence
Cegedim SA's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
Score
Cegedim SA's profitability score is 45/100. The higher the profitability score, the more profitable the company is.
CGM Solvency Score
Solvency Due Diligence
Cegedim SA's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Score
Cegedim SA's solvency score is 31/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CGM Price Targets Summary
Cegedim SA
According to Wall Street analysts, the average 1-year price target for CGM is 16.5 EUR with a low forecast of 14.14 EUR and a high forecast of 21 EUR.
Dividends
Current shareholder yield for CGM is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Cegedim SA operates as a technology and services company, which engages in the digital data flow management for healthcare ecosystems and B2B. The company is headquartered in Boulogne-Billancourt, Ile-De-France and currently employs 5,643 full-time employees. Cegedim is also a manufacturer of medical and para-medical management software, and designs management applications dedicated to the health insurance sector. The Company’s expertise falls into three sectors: Life Sciences which comprises solutions specifically designed for pharmaceutical companies; Healthcare professionals designed for doctors, pharmacists and paramedics, and Healthcare Insurance, which is designed for health insurance providers and for companies of any sectors. The firm operates through Webstar Health and a number of subsidiaries. Cegedim SA is present in approximately 80 countries around the world.
Contact
IPO
Employees
Officers
The intrinsic value of one CGM stock under the Base Case scenario is 33.97 EUR.
Compared to the current market price of 11.3 EUR, Cegedim SA is Undervalued by 67%.